Insider Transactions in Q1 2024 at Moelis & CO (MC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.66%
|
-
|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.02%
|
-
|
|
Mar 28
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.96%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.9%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.02%
|
-
|
|
Mar 28
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.97%
|
-
|
|
Mar 28
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.9%
|
-
|
|
Mar 28
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.02%
|
-
|
|
Mar 28
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.9%
|
-
|
|
Mar 01
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
19,483
-30.22%
|
$1,032,599
$53.88 P/Share
|
|
Mar 01
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
4,000
-4.63%
|
$216,000
$54.08 P/Share
|
|
Feb 29
2024
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,573
-100.0%
|
$462,942
$54.13 P/Share
|
|
Feb 29
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
50,772
-44.06%
|
$2,741,688
$54.11 P/Share
|
|
Feb 29
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
75,000
-46.46%
|
$4,050,000
$54.11 P/Share
|
|
Feb 29
2024
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
44,710
-100.0%
|
$2,414,340
$54.23 P/Share
|
|
Feb 23
2024
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
45,093
-50.21%
|
$2,435,022
$54.62 P/Share
|
|
Feb 23
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
400
-0.25%
|
$22,000
$55.0 P/Share
|
|
Feb 23
2024
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+0.02%
|
-
|
|
Feb 23
2024
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
5,869
-97.82%
|
$316,926
$54.38 P/Share
|
|
Feb 22
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
10,402
-8.28%
|
$561,708
$54.92 P/Share
|
|
Feb 21
2024
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,149
-48.73%
|
$423,748
$52.6 P/Share
|
|
Feb 21
2024
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.01%
|
$52
$52.6 P/Share
|
|
Feb 21
2024
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,723
+50.0%
|
-
|
|
Feb 21
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
106,211
-39.04%
|
$5,629,183
$53.64 P/Share
|
|
Feb 21
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$52
$52.6 P/Share
|
|
Feb 21
2024
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
177,632
+35.64%
|
-
|
|
Feb 21
2024
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
39,781
-30.7%
|
$2,068,612
$52.6 P/Share
|
|
Feb 21
2024
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$52
$52.6 P/Share
|
|
Feb 21
2024
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
84,875
+29.13%
|
-
|
|
Feb 21
2024
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,144
-56.38%
|
$59,488
$52.6 P/Share
|
|
Feb 21
2024
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.1%
|
$104
$52.6 P/Share
|
|
Feb 21
2024
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,031
+50.0%
|
-
|
|
Feb 21
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Open market or private sale
|
Direct |
17,857
-8.36%
|
$928,564
$52.6 P/Share
|
|
Feb 21
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.0%
|
$156
$52.6 P/Share
|
|
Feb 21
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
40,618
+15.97%
|
-
|
|
Feb 21
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
128,277
-44.22%
|
$6,670,404
$52.6 P/Share
|
|
Feb 21
2024
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
0
|
$0
$52.6 P/Share
|
|
Feb 21
2024
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
284,779
+44.5%
|
-
|
|
Feb 21
2024
|
Ciafone Katherine Pilcher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,798
-56.69%
|
$249,496
$52.6 P/Share
|
|
Feb 21
2024
|
Ciafone Katherine Pilcher Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.01%
|
$52
$52.6 P/Share
|
|
Feb 21
2024
|
Ciafone Katherine Pilcher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,465
+50.0%
|
-
|
|
Feb 21
2024
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
7,685
-56.16%
|
$399,620
$52.6 P/Share
|
|
Feb 21
2024
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.01%
|
$52
$52.6 P/Share
|
|
Feb 21
2024
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,555
+49.76%
|
-
|
|
Feb 20
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
25,642
-32.11%
|
$1,410,310
$55.29 P/Share
|
|
Feb 16
2024
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
20,001
-20.03%
|
$1,100,055
$55.82 P/Share
|
|
Feb 09
2024
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,720
-61.57%
|
$578,880
$54.7 P/Share
|
|
Feb 08
2024
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,040
-100.0%
|
$55,120
$53.59 P/Share
|
|
Feb 08
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
764
-0.44%
|
$41,256
$54.69 P/Share
|
|
Feb 08
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,736
+0.99%
|
-
|